Warrants Finder
Your selection:
426 Results
| FD1V2V | Vertex Pharmaceuticals Inc./OS/Call [340]/SOC | - | - | 340.000 | call | Vertex Pharmaceuticals Inc. | - | - | - | - | - | 01/15/2027 | 0.100 | Société Générale | ||
| GU1LER | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350.000 | call | Vertex Pharmaceuticals Inc. | - | 46.726% | 0.888 | -0.074 | 2.853 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GU1LEW | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350.000 | call | Vertex Pharmaceuticals Inc. | - | 53.878% | 0.947 | -0.082 | 3.330 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GU1LKH | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350.000 | call | Vertex Pharmaceuticals Inc. | - | 45.834% | 0.903 | -0.073 | 2.984 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| FD1ZF5 | Vertex Pharmaceuticals Inc./OS/Call [350]/SOC | - | - | 350.000 | call | Vertex Pharmaceuticals Inc. | - | 48.109% | 0.863 | -0.073 | 2.626 | 03/19/2027 | 0.100 | Société Générale | ||
| FD1V2W | Vertex Pharmaceuticals Inc./OS/Call [360]/SOC | - | - | 360.000 | call | Vertex Pharmaceuticals Inc. | - | 47.308% | 0.868 | -0.081 | 2.936 | 01/15/2027 | 0.100 | Société Générale | ||
| MM215M |  | Vertex Pharmaceuticals Inc./OS/Call [375]/MS | - | - | 375.000 | call | Vertex Pharmaceuticals Inc. | - | 49.690% | 0.843 | -0.010 | 3.154 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM215N | | Vertex Pharmaceuticals Inc./OS/Call [375]/MS | - | - | 375.000 | call | Vertex Pharmaceuticals Inc. | - | 48.850% | 0.805 | -0.008 | 2.539 | 06/17/2027 | 0.010 | Morgan Stanley | |
| GW4K28 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 42.381% | 0.815 | -0.068 | 2.766 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW52A5 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 43.576% | 0.825 | -0.077 | 3.002 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5YD6 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 43.191% | 0.845 | -0.083 | 3.279 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| FD1V2X | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 45.269% | 0.838 | -0.087 | 3.203 | 01/15/2027 | 0.100 | Société Générale | ||
| FD1YTL | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | - | - | - | - | 09/18/2026 | 0.100 | Société Générale | ||
| FE4XZ0 | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 44.094% | 0.854 | -0.087 | 3.396 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58HF | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 45.990% | 0.817 | -0.081 | 2.919 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58UV | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 44.521% | 0.808 | -0.071 | 2.699 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VC | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380.000 | call | Vertex Pharmaceuticals Inc. | - | 44.192% | 0.794 | -0.057 | 2.325 | 01/21/2028 | 0.100 | Société Générale | ||
| GJ8XFZ | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 40.661% | 0.821 | -0.091 | 3.826 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GJ9UEE | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 41.598% | 0.807 | -0.089 | 3.587 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GV70P1 | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.599% | 0.884 | -0.113 | 4.716 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV87SP | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 41.436% | 0.780 | -0.072 | 2.950 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GU3QTR | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 41.680% | 0.806 | -0.089 | 3.585 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GU3QWZ | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 41.343% | 0.781 | -0.071 | 2.954 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW0KKU | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.866% | 0.767 | -0.059 | 2.416 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW2MV9 | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 42.347% | 0.788 | -0.082 | 3.234 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| JU31UG | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 46.222% | 0.872 | -0.124 | 4.611 | 09/18/2026 | 0.100 | JP Morgan | ||
| JU22GB | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 45.013% | 0.795 | -0.096 | 3.432 | 01/15/2027 | 0.100 | JP Morgan | ||
| JU3FQ5 | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.702% | 0.809 | -0.098 | 3.680 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM215P | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 47.190% | 0.768 | -0.008 | 2.729 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM215Q | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 46.222% | 0.801 | -0.010 | 3.565 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM5JNX | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 53.778% | 0.843 | -0.016 | 4.294 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MR15AY | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 48.120% | 0.773 | -0.009 | 2.998 | 03/19/2027 | 0.010 | Morgan Stanley | |
| FA53J8 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 42.479% | 0.814 | -0.095 | 3.734 | 12/18/2026 | 0.100 | Société Générale | ||
| FD1V2Y | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 44.156% | 0.797 | -0.095 | 3.473 | 01/15/2027 | 0.100 | Société Générale | ||
| FD1ZF6 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 44.645% | 0.782 | -0.086 | 3.133 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58HB | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 46.154% | 0.873 | -0.124 | 4.604 | 09/18/2026 | 0.100 | Société Générale | ||
| FE58U4 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.857% | 0.767 | -0.066 | 2.639 | 09/17/2027 | 0.100 | Société Générale | ||
| FE58U8 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.370% | 0.767 | -0.061 | 2.488 | 12/17/2027 | 0.100 | Société Générale | ||
| FE58UW | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.552% | 0.776 | -0.075 | 2.863 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VD | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 43.199% | 0.768 | -0.059 | 2.438 | 01/21/2028 | 0.100 | Société Générale | ||
| VH628B | | Vertex Pharmaceuticals Inc./OS/Call [400]/VONT | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 44.621% | 0.796 | -0.096 | 3.452 | 01/15/2027 | 0.100 | Vontobel | |
| VY37YC | | Vertex Pharmaceuticals Inc./OS/Call [400]/VONT | - | - | 400.000 | call | Vertex Pharmaceuticals Inc. | - | 42.034% | 0.815 | -0.094 | 3.760 | 12/18/2026 | 0.100 | Vontobel | |
| JU31UE | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410.000 | call | Vertex Pharmaceuticals Inc. | - | 45.387% | 0.846 | -0.136 | 4.928 | 09/18/2026 | 0.100 | JP Morgan | ||
| JU26QC | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410.000 | call | Vertex Pharmaceuticals Inc. | - | 43.065% | 0.786 | -0.102 | 3.851 | 12/18/2026 | 0.100 | JP Morgan | ||
| JU355A | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410.000 | call | Vertex Pharmaceuticals Inc. | - | 44.541% | 0.773 | -0.100 | 3.569 | 01/15/2027 | 0.100 | JP Morgan | ||
| GW3T1P | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 41.286% | 0.748 | -0.086 | 3.479 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW3T4G | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 40.542% | 0.744 | -0.075 | 3.139 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW3T4K | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 40.661% | 0.760 | -0.096 | 3.901 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| JU34AE | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 44.507% | 0.817 | -0.147 | 5.267 | 09/18/2026 | 0.100 | JP Morgan | ||
| JU355E | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 43.984% | 0.751 | -0.103 | 3.711 | 01/15/2027 | 0.100 | JP Morgan |